Literature DB >> 1758839

Evaluation of two biological markers of tobacco exposure. MRFIT Research Group.

K J Ruth1, J D Neaton.   

Abstract

This study assesses serum thiocyanate and expired-air carbon monoxide based on findings for 8,895 participants in the Multiple Risk Factor Intervention Trial. For each marker and combination of markers, a logistic probability model was used to generate a plot of true positive vs false positive rates (an operating characteristic curve), an optimal cutpoint, and the positive predictive value for discriminating tobacco smokers (cigarettes, pipes, cigars, or cigarillos) from non-tobacco smokers. Optimal cutpoints were 83 mumols/liter for thiocyanate and 10 ppm for carbon monoxide. These cutpoints were applied to the entire group to evaluate accuracy. Specificity was higher for carbon monoxide than for thiocyanate (91.8 vs 87.3%) and sensitivity was lower (85.7% for carbon monoxide vs 88.8% for thiocyanate). When carbon monoxide and thiocyanate were both used, specificity was 92.7% and sensitivity was 89.1%. The estimated cutpoints derived from the Multiple Risk Factor Intervention Trial result in predictive values greater than 87% when the prevalence of smokers is greater than 50%. Cutpoints should be modified to maximize the predictive value when the prevalence of smokers is less than 50%. Both serum thiocyanate and carbon monoxide are good markers of smoking exposure. Serum thiocyanate may be preferable to carbon monoxide because of its longer half-life.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1758839     DOI: 10.1016/0091-7435(91)90056-a

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  9 in total

1.  Smoking prevalence among US veterans.

Authors:  David W Brown
Journal:  J Gen Intern Med       Date:  2009-11-06       Impact factor: 5.128

2.  Error in smoking measures: effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking. The Lung Health Study Research Group.

Authors:  R P Murray; J E Connett; G G Lauger; H T Voelker
Journal:  Am J Public Health       Date:  1993-09       Impact factor: 9.308

3.  Cigarette smoking and random serum cholesterol levels in a Northern Ireland general practice population of 18- to 20-year-old students and non-students.

Authors:  J S Brown; K Steele
Journal:  Br J Gen Pract       Date:  1996-11       Impact factor: 5.386

4.  Serum thiocyanate concentration as an indicator of smoking in relation to deaths from cancer.

Authors:  H Wang; M Sekine; H Yokokawa; S Hamanishi; M Sayama; Y Naruse; H Nakagawa; S Kagamimori
Journal:  Environ Health Prev Med       Date:  2001-07       Impact factor: 3.674

5.  Nanoparticles And Human Saliva: A Step Towards Drug Delivery Systems For Dental And Craniofacial Biomaterials.

Authors:  Rafal Pokrowiecki; Jacek Wojnarowicz; Tomasz Zareba; Iwona Koltsov; Witold Lojkowski; Stefan Tyski; Agnieszka Mielczarek; Pawel Zawadzki
Journal:  Int J Nanomedicine       Date:  2019-11-27

Review 6.  Putting together the psoriasis puzzle: an update on developing targeted therapies.

Authors:  Leanne M Johnson-Huang; Michelle A Lowes; James G Krueger
Journal:  Dis Model Mech       Date:  2012-07       Impact factor: 5.758

7.  Diabetes-related molecular signatures in infrared spectra of human saliva.

Authors:  David A Scott; Diane E Renaud; Sathya Krishnasamy; Pinar Meriç; Nurcan Buduneli; Svetki Cetinkalp; Kan-Zhi Liu
Journal:  Diabetol Metab Syndr       Date:  2010-07-14       Impact factor: 3.320

Review 8.  Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.

Authors:  Ping Wu; Kumanan Wilson; Popey Dimoulas; Edward J Mills
Journal:  BMC Public Health       Date:  2006-12-11       Impact factor: 3.295

9.  Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.

Authors:  Edward J Mills; Ping Wu; Dean Spurden; Jon O Ebbert; Kumanan Wilson
Journal:  Harm Reduct J       Date:  2009-09-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.